From February 19, 2024 to March 31, 2024, the company has repurchased 3,860,109 shares, representing 0.85% for CNY 32.31 million. With this, the company has completed the repurchase of 3,860,109 shares, representing 0.85% for CNY 32.31 million under the buyback announced on February 21, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 CNY | +1.09% | +1.09% | -24.32% |
26/06 | Sinotherapeutics Secures Regulatory Nod for Two Drugs | MT |
29/04 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-24.32% | 51Cr | |
+20.70% | 4.38TCr | |
+28.29% | 2.28TCr | |
+18.68% | 1.43TCr | |
+54.86% | 1.3TCr | |
-0.05% | 678.76Cr | |
-11.63% | 641.27Cr | |
-8.87% | 572.55Cr | |
+12.21% | 568.66Cr | |
+9.49% | 475.06Cr |
- Stock Market
- Equities
- 688247 Stock
- News Sinotherapeutics Inc.
- Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.